Introduction. Post-laminectomy syndrome (PLS) patients who have previously undergone spinal cord stimulation and failed to have significant improvement create a unique challenge for ongoing pain management. We hypothesize that, following successful completion of intensive, interdisciplinary pain rehabilitation (IPR), this patient population can achieve a significant reduction in pain, improvement in mood, functional levels, and self-efficacy.
Introduction
Post-laminectomy syndrome (PLS) is a diagnosis of persistent and/or recurring back and leg pain for more than six months after the spine surgery [1, 2] . Patients suffering from neuropathic pain secondary to PLS have been shown to experience greater levels of pain, lower quality of life, and decreased function compared with patients with other more widely recognized chronic pain conditions such as rheumatoid arthritis, osteoarthritis, fibromyalgia, and complex regional pain syndrome [3] . The health care cost of PLS also exceeds that of the aforementioned conditions [3] . The incidence of PLS after lumbar spinal surgery is between 10% and 40% [2,4,5], and the surgical success rate falls if the patient undergoes subsequent surgeries [1, 2] .
While spinal cord stimulation (SCS) has been shown to provide a sustained level of long-term pain relief for patients with PLS [6], some patients fail to respond to the therapy, and others who initially received benefit can eventually fail or develop diminished pain control over time [7] . This subset of patients provides a unique challenge for ongoing pain management in that they have exhausted most interventional modalities. In the past, this group has been treated primarily with escalating opioid doses, including intrathecal drug delivery systems [8, 9] . Maintenance of benign patients with opioid analgesics is controversial [10] [11] [12] . Several organizations, including most recently the American Academy of Neurology, have shown that ongoing high-dose opioid treatment for chronic nonmalignant pain leads to increased prescription opioid morbidity and mortality [13, 14] . Recently the US Centers for Disease Control and Prevention has published guidelines for the use of opioids in chronic pain that aim to control their use [12] .
Intensive, interdisciplinary pain rehabilitation (IPR) programs have been shown to improve pain intensity and physical functioning in chronic noncancer pain patients [15, 16] . It has been demonstrated that back pain patients can achieve significant benefits from this type of program, which also incorporates opioid withdrawal as a part of the treatment [15, 17] , thus removing the risks associated with ongoing opioid maintenance and escalating doses. It has also been shown that the successful completion of an intensive IPR program reduces the financial burden that patients place on the health care system at large by significantly decreasing medical expenses [18] .
The present study was conducted to test the hypothesis that a specific subset of patients with PLS who successfully complete an intensive three-week IPR program that includes a concurrent withdrawal of opioid analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), benzodiazepines, and muscle relaxants can achieve a significant reduction in pain and improvement in mood, functional levels, and self-efficacy.
Methods

Population and Study Design
A retrospective chart review was conducted to identify patients who successfully completed the three-week intensive IPR program at Mayo Clinic Florida during a three-year period spanning from October 2011 to October 2014. Patients who met inclusion criteria had the diagnosis of PLS and had undergone at least one SCS trial or SCS implant per their PRC admission history and physical, yet continued to suffer severe pain. Patients were excluded from consideration if they had received a SCS for another diagnosis or had not completed the PRC program in full.
The Pain Rehabilitation Center Program
The Mayo Clinic Pain Rehabilitation Center program is an intensive three-week IPR outpatient treatment program. It provides interdisciplinary rehabilitative therapy to patients with chronic pain with the goal of improving their quality of life and facilitating a return to regular daily activities. The program is focused on functional restoration. A cognitive-behavioral model serves as the basis for the treatment and incorporates physical reconditioning, biofeedback and relaxation training, stress management, chemical health education, activity moderation, and cognitive restructuring to decrease pain catastrophizing and pain anxiety.
Cognitive-Behavorial Therapy
The cognitive-behavioral therapy component consists of three one-hour group sessions per day. The topics covered include stress management; behavior therapy for anxiety, depression, and anger; instruction in sleep hygiene, relaxation strategies, and maintenance of treatment gains; and review of topics including central sensitization, pain behaviors, and cycles of pain. The chemical health element includes an explicit discussion of the negative consequences of polypharmacy. Issues of chemical dependence and addiction are explained and discussed.
Physical Reconditioning
All patients participate in a functional restoration-type rehabilitation program consisting of graded exposure to exercise (three sessions daily). The program is a general rehabilitation program (not spine specific) supervised by a physical therapist. The program includes stretching, aerobic conditioning, and low weight resistance training. The goals are to address maladaptive behaviors related to pain and activity and to initiate a sustainable program to reverse the generalized deconditioned state. Occupational therapists teach concepts of structuring activity, moderation of effort, balancing activity, fear avoidance, functional independence, and participation in life roles. EMG biofeedback/relaxation training is also incorporated.
Measures
Medication List
Upon the start of the program, patients provide a detailed list of their current medications. A risk benefit assessment regarding a patient's medications is performed. Medications such as opioids, stimulants, and benzodiazapines are tapered off during the threeweek program [17] . Medications such as sleep aids, muscle relaxants, NSAIDs, and dietary supplements are tapered off as well if deemed inappropriate for long-term use. Anticonvulsant and antidepressant analgesics with central neuromodulatory effects are often continued if deemed effective by the patient and appropriate by the admitting physician. Medication tapers are recorded in the electronic medical record by physician assistants and nurses from the Department of Pain Medicine. The medication list, as well as the taper schedules, is obtained from the electronic medical records. Opioid use is recalculated into oral morphine equivalents (OMEs).
Pain Scores, Self-Efficacy, Depression Scale, Multidimensional Pain Inventory, Short Form-36, and Pain Catastrophizing At the beginning and at the completion of the program, patients complete the computer-based Research Electronic Data Capture Questionnaire (REDCap) questionnaire. REDCap is a web type of application for building and managing online surveys and databases originally built at Vanderbilt University. The questionnaire and data from our REDCap database were available on the institutional internal server. Our REDCap questionnaire was composed of questions regarding pain scores, pain self-efficacy, The Center for Epidemiologic Studies Depression Scale, Multidimensional Pain Inventory, Short Form-36 (SF-36) status, the Pain Catastrophizing Scale, and demographics.
Measure of Pain
Pain scores were assessed via the numeric rating scale (NRS) pain scale, 0 to 10 (0 ¼ no pain at all, 10 ¼ the worst pain imaginable) [19] .
Pain Self-Efficacy Questionnaire Self-efficacy was assessed utilizing the Pain SelfEfficacy Questionnaire (PSEQ) [20] . This is a 10-item questionnaire with answers on a 0-6 scale (0 ¼ not confident at all, 6 ¼ completely confident); the final score was achieved by adding numerical answers [21] .
Measure of Depressive Symptoms-the Center for Epidemiologic Studies Depression Scale Depression was measured with the Center for Epidemiologic Studies Depression Scale (CES-D) [22] . CES-D is a 20-item questionnaire; answers are converted into 0-3 scale and added up. Total scores range from 0 to 60; higher scores indicate greater levels of depression. A score of 16 or higher represents minor depressive symptoms [23] , and a score of 27 or higher represents major depression in patients with chronic pain [24] .
Measure of Pain Interference and Perceived Control
Over Pain and Life Events-Multidimensional Pain Inventory For evaluation of the impact of pain on an individual's life, we used the Multidimensional Pain Inventory (MPI) [25] , a 52-question questionnaire containing nine primary scales.
Items are rated on a seven-point scale (0 ¼ not at all, 6 ¼ a great deal of control). The raw scores are converted to standardized T scores with a range of 0 to 100 [26] . Two subscales used in this study were Interference and Life Control. The interference subscale assesses the interference of pain in relationships and daily activities (100 ¼ worst; Interference: (Question 2 þ 3 þ 4 þ 8 þ 9 þ 13 þ 14 þ 17 þ 19)/9). The life control subscale is a measure of problem management and overall coping skills, 100 = best. Life-Control: (Question 11+16)/2.
Measures of the Patient's Physical and Emotional Health-SF-36 Health Survey
The patient's physical and emotional health attributes for the last month were measured with the SF-36 health survey with 36 questions [27] . The raw scores were converted to T scores, with a normative from the general US population, using published age-and sexspecific mean scores and standard deviations [28] . Higher scores for the health perception subscale reflect a belief that personal health is better [27] [28] [29] .
Measure of Pain Catastrophizing-the Pain Catastrophizing Scale Pain catastrophizing has been described as an exaggerated negative mental set associated with actual or anticipated pain experiences [30] . The PCS is comprised of 13 questions scored on a five-point scale from 0 (not at all) to 4 (all the time) [31] . A total PCS score of 30 points corresponds to the 75th percentile of the distribution of PCS scores in clinical samples in patients with chronic pain [32] .
Demographic Data
Demographic data was collected from the patient's electronic medical records and our REDCap database.
Functional Assessment
Functional assessment was conducted via the six-minute walk test (6mWT), a submaximal, performancebased measure of functional capacity [33] [34] [35] [36] [37] [38] [39] [40] . The 6mWT was performed on day 1 of admission and day
Effectiveness of an Intensive Interdisciplinary Pain Rehabilitation Program
15. For each patient, the 6mWT was performed by one of the four physical therapists at our practice. A 100-foot (30.48 m), demarcated, up-and-back walkway was used, along with a stopwatch to keep time. Before the test began, instructions were given to walk up and down the hallway safely covering as much distance as possible in six minutes, without running. Patients were further instructed to only take rest breaks if needed. During the test, time updates were provided every 30 to 60 seconds without encouragement [41] .
Statistical Analysis
Study outcomes were compared using the Student's t test. For REDCap data analysis, IBM SPSS Statistics, version 19.0.0 (IBM Corporation, New York, NY, USA) was used; all other statistical analyses were performed using JMP, version 10.0.0. The results were considered statistically significant at the 0.05 level.
Results
Between October 2011 and October 2014, 44 patients with PLS and failed SCS were admitted to the IPR program; one patient did not finish the program in full and was excluded from this study. Out of 43 patients who finished the IPR program, most patients were females 60.5%, married 74%, and white 97.6%. Their average education was 14.5 years (Table 1) . Patients who were on permanent SCS had it on average for 2.7 years prior to joining the IPR program.
Thirty-one patients were using opioids at the beginning of the IPR program, and their average OME at admission was 108 mg/day. All patients were tapered off all opioids by the end of the PRC program. The average chronic pain duration at the admission was 13 years (Table 1 ). All patients were also successfully tapered of NSAIDS, benzodiazepines, muscle relaxants, sleep medications, supplements, and antidepressants.
Admission and dismissal subscale scores for patient questionnaires are listed in Table 2 . The average pain score was 6.5 on admission and 5.1 on completion (P ¼ 0.0038). After completion of the program, patients reported significant improvements in both MPI scores, MPI Life Control (P < 0.0001) and MPI Interference (P ¼ 0.0001). Analyses of the admission and discharge subscale scores for the SF-36 Health Perception and PSEQ showed significant improvement as well (P < 0.0001 for both). There were also significant improvements in the average admission and discharge scores from the PCS and CES-D scales, indicating significant decreases in depressive symptoms and negative pain-related cognition.
The average 6mWT results were 312 m at admission and 416 m at discharge (P < 0.0001). We had one patient who couldn't be tested using the six-minute test due to fall risk.
Discussion
To our knowledge, this is the first study to investigate improvement in pain-related impairments after an intensive, interdisciplinary pain rehabilitation program in patients with PLS who have failed SCS. Patients demonstrated significant improvements in a spectrum of domains, including pain, pain self-efficacy, pain catastrophizing, depression, life control measures, interference of pain measures, health perception measures, and physical function.
IPR programs have previously demonstrated efficacy in refractory chronic pain conditions including fibromyalgia [42, 43] , chronic headache [44] , low back pain [45, 46] , and stable multiple sclerosis [47] , and some limited evidence has demonstrated efficacy in neuropathic pain patients [48] . Patients enrolled in this intensive outpatient pain treatment program have failed all reasonable treatments including standard outpatient physical therapy, multiclass medication therapies, intraventional procedures, and surgeries. Many have experienced years of pain and pain-related disability. The average pain duration of subjects in this study was 13 years, and most patients were not working. Despite these challenges, subjects were able to achieve significant improvements in pain, as well as other domains including function, mood, and coping abilities. Many were dependent on opioids (72%) at study entry, and all were opioid free at discharge.
SCS is an established and effective treatment for PLS [49] [50] [51] ; however, not all patients respond to the therapy. Additionally, patients sometimes experience decreased efficacy of SCS therapy over time (perhaps due to disease progression or accommodation to the stimulation itself) [52] . PLS patients enrolled in this study continued to have high levels of pain, low levels of function, and poor quality of life despite standard comprehensive treatment (including SCS). Over the course of three weeks, patients participating in this intensive IPR program were able to achieve many significant improvements.
Though it is notable that the overall magnitude of pain improvement as measured by the NRS was not profound (6.5 on admission and 5.1 on discharge), this approaches standards of accepted criteria for clinically significant improvement, where a one-unit drop on the NRS is seen as mild improvement [53] and 15% change is seen as a minimum level of clinical importance for mild to moderate pain [54] . Furthermore, most patients tapered off of significant amounts of opioid (greater than 100 mg OME) during the three-week program. Thus, an average decrease in pain of 1.4 (NRS) in this context is very rewarding. The most important benefits of this treatment approach, however, may be in the ability to achieve significant improvements in function, mood, coping abilities, and self-efficacy.
A growing base of research supports that the level of PSEQ is a significant contributor to the extent that a person is disabled by their chronic pain. PSEQ refers to personal judgments of how well a person believes he or she can perform specific behaviors in particular situations. PSEQs around 40 have been shown to be associated with return to work and maintenance of functional gains [55] . Lower scores (around 30) after treatment tend to predict less sustainable gains [56] .
Low PSEQ has also been shown to be a predictor of risk of long-term disability and depression [57] . Higher PSEQ has been shown to enhance and maintain the long-term effects of rehabilitation (3). PSEQ scores in our patients went from an average of 25.7 on admission to 43.8 on discharge.
Patients experienced improvement at the 6mWT, from 312 m to 416 m, where the improvement of 54 m is clinically significant [58] ; however, even after the completion of the program, our patients were below the normal values for the 60-to 69-year-old group, for which 572 m for males and 538 m for females was reported previously [59] .
The average perceived life control after the three-week program for our patients increased by 8.3 points, which is significant both statistically and clinically [60, 61] . The interference score dropped by 5.3 points, a marked improvement both statistically and clinically [60, 61] .
The SF-36 GH assesses patient health status and wellbeing, it compares overall perception of patient health to the functioning of healthy peers who are the same age and gender. Previously reported SF-36 GH means for a 55-to 64-year-old population group are 62.87 for females and 66.58 for males [59] . In a lower back pain population, the mean SF-36 GH was reported to be 48.2 [62] . Our population's SF-36 GH on admission was 43.0, and by the end of the treatment program SF-36 GH scores increased 6.5 points, which corresponds to clinically important differences [63] .
CES-D scores of 16 or higher represent minor depressive symptoms [23] , and a score of 27 or higher represents major depression in patients with chronic pain [24] . In the beginning of the program, our patients' CES-D score was 19.9, and by the end of the program, our patients average CES-D went down to 15.7, improving patients' depressive symptoms from minor to normal CES-D scores [23, 24] .
The PCS after the completion of the three-week program went below 20, which indicates improvement [64] . Catastrophizing in chronic pain patients is linked to higher pain intensity, higher disability, and psychological distress [65] .
The major limitation of the study is the lack of long-duration follow-up data, which is due to the retrospective nature of the study design. Long-term outcomes have been previously published for chronic noncancer pain [66] and geriatric patients with chronic noncancer pain [67] at our institution. We are currently engaged in prospectively following our patients for quality of life, pain score measures, and medication usage for long-term outcomes.
Conclusions
In conclusion, this study provides evidence that postlaminectomy syndrome patients who have previously undergone spinal cord stimulation and failed can benefit 
